ProGnosis Biotech made the first step in the Clinical Diagnostics field with Rapid Test Ag 2019 n-CoV and is now is lauching the new additions to its catalog.
A whole new line of Clinical Diagnostics is available to offer solution for the ongoing battle against viruses. Our new Rapid Tests can detect, with high specificity and sensitivity, the presence of specific viral antigens, indicative of
The new products include:
• Combo Rapid Test that differentiates between SARS-CoV-2 virus (COVID-19) and the Flu (influenza A&B).
• Flu Rapid Test that differentiates between Influenza A and Influenza B.
• Rapid Test that detects Adenoviruses that cause respiratory illness
• Rapid Test that detects the Respiratory Syncytial Virus (RSV).